Abnormal uterine bleeding (especially functional uterine bleeding unrelated to pregnancy)
Forms and strengths
500 mg tablet
Dosage and duration
Adolescent and adult: 1 g 3 times daily (max. 1 g 4 times daily) until bleeding stops (max. 5 days)
Contra-indications, adverse effects, precautions
Do not administer in patients with (or with history of) venous or arterial thromboembolic disorders, severe renal impairment, history of seizures.
Reduce dosage in patients with mild to moderate renal impairment (risk of accumulation).
May cause: gastrointestinal disturbances, seizures with high doses, visual disturbances, allergic reactions.
Avoid combination with drugs that increase the risk of thromboembolism. Concomitant use of oestrogens (e.g. ethinylestradiol/levonorgestrel) should be carefully considered on a case-by-case basis.
Pregnancy: this drug is not indicated in the event of bleeding during pregnancy.
Breast-feeding: no contra-indication
Remarks
The treatment may be administered at each bleeding episode. In situations of repeated bleeding,it may be helpful to combine tranexamic acid with a non-steroidal anti-inflammatory drug and/or a long-term treatment with a levonorgestrel intrauterine device or ethinylestradiol/levonorgestrel or oral or injectable medroxy progesterone.